Evaluating the Safety of Oral Propranolol Therapy in Patients With PHACE Syndrome

Abstract

This study found that oral propranolol was used to treat infantile hemangioma in 76 patients with PHACE syndrome and that no serious adverse events were experienced. These data provide support for the safety of oral propranolol in this patient population.